ABVC BioPharma Stock (NASDAQ: ABVC) stock price, news, charts, stock research, profile.
Open | $1.110 |
Close | $1.100 |
Volume / Avg. | 1.317M / 1.128M |
Day Range | 1.060 - 1.240 |
52 Wk Range | 0.674 - 9.600 |
Market Cap | $11.511M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 6.91% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ABVC BioPharma (NASDAQ: ABVC) through any online brokerage.
Other companies in ABVC BioPharma’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN), Dominari Holdings (NASDAQ:DOMH) and Monopar Therapeutics (NASDAQ:MNPR).
The latest price target for ABVC BioPharma (NASDAQ: ABVC) was reported by Maxim Group on Wednesday, November 16, 2022. The analyst firm set a price target for 0.00 expecting ABVC to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for ABVC BioPharma (NASDAQ: ABVC) is $1.09 last updated Today at May 9, 2024 at 4:57 PM EDT.
There are no upcoming dividends for ABVC BioPharma.
ABVC BioPharma’s Q1 earnings are confirmed for Tuesday, May 21, 2024.
There is no upcoming split for ABVC BioPharma.
ABVC BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.